# clm_10AEF85D5BA1

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_research_and_development  
value: 1,040,400,000 United States dollar  
valid_from: 2009-06-30  
valid_to: 2009-09-30  
published: 2009-07-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_15E0E04D9E8A  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly research and development: 1,040,400,000 United States dollar", as of 2009-06-30 (until 2009-09-30). Claim clm_10AEF85D5BA1, https://asof.is/claim/clm_10AEF85D5BA1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000095012309028099/0000950123-09-028099-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000095012309028099/0000950123-09-028099-index.htm (primary, SEC EDGAR 10-Q Q2 FY2009, published 2009-07-31)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_research_and_development | 947,300,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_10AEF85D5BA1](/claim/clm_10AEF85D5BA1.md) | [clm_F12D855DD720](/claim/clm_F12D855DD720.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.